Skip to main content

AZN · Astrazeneca PLC · Debt

Track AZN — free
$184.02 -0.43 (-0.23%) At close · Nov 16 Q1 2026 earnings call transcript
Market Cap
$285.40B
Shares
1.55B
Volume · Nov 16 1.95M Avg daily vol (3M) 3.03M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2026-06-30 USD 32,239,000,000 6-K filed 2026-07-27
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current borrowings, including current portion of noncurrent borrowings
USD 5,808,000,000
Current portion of long-term borrowings
USD 2,859,000,000
Noncurrent long-term borrowings
USD 23,683,000,000
Current lease liabilities 2026-06-30 USD 426,000,000 6-K filed 2026-07-27
Noncurrent lease liabilities 2026-06-30 USD 2,322,000,000 6-K filed 2026-07-27
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 901832 CUSIP G0593M107 13F (30d) 1094 filings 1075 filers Visit website Investor relations